Anlit has been granted GMP certification by the Australian Therapeutic Goods Administration (TGA), the governmental authority charged with regulating therapeutic goods for the protection of public health and safety. The certification was granted to Anlit’s Kidi Bites, a supplement format designed specifically for children.
“Anlit approached this certification as a strategic move, designed to bring our products to the global forefront of quality and excellence,” said Shai Karlinski, marketing VP for Anlit. “Anlit had to follow a fast learning curve, forging beyond the former food supplement paradigms and adopting new pharma concepts and processes.”
Anlit said that attaining the TGA stamp of approval is part of its strategy for pursuing the highest and most stringent quality standards, paving the way to partnerships with global pharmaceutical companies that are seeking diversification of their product portfolio with unique food supplements.
“Thanks to this important certification, Sanofi Aventis, Australia, just launched two of our innovative Kidi Bites supplements for children — Multivitamin and Calcium — in Australia,” said Karlinski.
Anlit says that its Kidi Bites Technology produces supplements focused on kids’ preferences and providing the essential health benefits children need. Their chocolaty flavour and texture is designed to overcome children’s typical reluctance to taking nutritional supplements.
